Oracle (ORCL) just booked the strongest sales year in its history, yet investors sold it anyway.
The stock trades near $143, down about 27% in 2026 and off more than 50% from its 52-week high near $346.
That kind of drop usually follows a bad quarter, but Oracle’s was the opposite of bad.
So the question for anyone holding the stock, or thinking about buying the dip, is simple. Why is Wall Street walking away from a company that keeps setting records?
Oracle closed fiscal 2026 with remaining performance obligations, or RPO, of $638 billion.
RPO is simply contracted work that the company has signed but not yet delivered. It is a preview of future revenue.
That figure jumped 363% from a year earlier and rose by $85 billion in the fourth quarter alone, according to Oracle's official earnings release.
For context, that backlog is worth roughly 1.5 times Oracle's entire market value, an unusual sign that demand is running ahead of what the stock price reflects.
Most of that growth traces back to one pivot. Oracle stopped being only a database and software vendor and started renting out AI infrastructure.
The company is positioning itself as a landlord for the data centers that train and run large AI models.
Oracle's record AI backlog has not stopped a steep 2026 selloff in ORCL shares.
d3sign &sol Getty Images
Building all that AI capacity costs real money up front, long before the contracts pay off.
Oracle spent about $56 billion on capital expenditures in fiscal 2026, up 162% from the prior year.
That resulted in a free cash flowdeficit of $23.7 billion, even as operating cash flowclimbed 54% to $32 billion, Reuters reported.
More AI Stocks:
In plain terms, Oracle is spending faster than its business generates cash, and it is funding the gap with debt and new stock.
The company plans to raise about $40 billion through debt and equity in fiscal 2027, including a $20 billion equity program that could dilute existing shareholders by roughly 5%, CNBC reported.
There is one more issue that unsettled investors.
According to an SEC filing, Oracle added a warning that its AI buildout could pressure profitability and that its AI products might not perform as expected.
Oracle signed a multiyear deal worth roughly $300 billion to supply data center capacity to OpenAI, Fortune reported.
Analysts estimate more than half of the $638 billion backlog may be tied to that relationship.
Related: Oracle stock falls for a seventh session as filing risk lands
That concentration goes both ways. If OpenAI's computing needs keep growing, Oracle wins big.
If OpenAI's demand or funding tightens, Oracle absorbs the loss through leases and debt already on its books.
This is the core risk investors are considering right now, and it explains why strong numbers have not been enough to steady the stock.
Oracle's slide looks worse next to peers that are riding the same AI wave.
The message from that gap is clear. The market is not doubting AI demand broadly. It is singling out Oracle's balance sheet and its heavy reliance on one anchor customer.
Oracle has to hit roughly $90 billion in revenue for fiscal 2027, a 34% jump, for its cloud contracts to turn into recognized sales.
Also, it has to sustain the momentum behind its cloud infrastructure revenue, which already grew 84% in the third quarter, far outpacing its larger rivals.
Wall Street still remains positive about the stock. As of early July, 28 of 32 analysts rated ORCL a Buy, with an average 12-month target at $263.86.
Oracle's problem is not demand. It is timing.
The company currently has the highest volume of contracted work in its history, but it has to spend tens of billions today to earn that revenue later.
Oracle is funding this gap with borrowed money and new shares.
For long-term investors, that trade-off can work if the backlog converts and margins hold.
For short-term investors, the cash burn and OpenAI concentration are real risks that could keep the stock volatile.
The next real test comes at Oracle's coming earnings report, when investors get updated on how fast that $638 billion backlog is turning into actual revenue. Until then, everything is still a debate.
Related: Bank of America aggressively revamps Oracle stock price target


